The Future of AI in Cardiology: Trends, Expert Insights and Panel Discussion 12:30-1:15 p.m. | Heart Theater II SUPPORTER: Anumana, Inc. Informing Cardiovascular Risk With Noninvasive Imaging and AI-Enabled Insights 3:15-3:45 p.m. | CardioTalk II SUPPORTER: Heartflow, Inc. Getting to the Heart of the Matter: Gene Therapy for Cardiac Diseases 3:15-4 p.m. | Heart Theater I SUPPORTER: Lexeo Therapeutics Inc Living on Borrowed Time: A Call to Action for Severe Aortic Stenosis Patients 3:15-4 p.m. | Learning Studio II SUPPORTER: Edwards Lifesciences, LLC Systemic Inflammation: Evaluating Potential New Targets in the Management of ASCVD and CKD 3:15-4 p.m. | Learning Studio I SUPPORTER: Novo Nordisk, Inc. Monday, Nov. 18 Taking a Closer Look at Management of Heart Failure Due to ATTR-CM in Today’s Era of Disease Monitoring 9:30-10:15 a.m. | Learning Studio II SUPPORTER: Pfizer Inc. The Hidden Risk Factor: The Underappreciated Aspects of Lp(a) in ASCVD 9:30-10:15 a.m. | Learning Studio I SUPPORTER: Amgen Inc. NHLBI Small Business Innovation Showcase 9:30-10:45 a.m. | Heart Theater I SUPPORTER: National Heart, Lung & Blood Institute (NHLBI) of the National Institutes of Health (NIH) Best Practices for Optimizing Telehealth to Improve Care for Older Adults 9:45-10:15 a.m. | CardioTalk II SUPPORTER: AHA Center for Telehealth Getting to the Heart of Stroke™: Deepening the Collaboration Between Neurology and Cardiology 11:15 a.m.-12 p.m. | Learning Studio II SUPPORTER: HCA Healthcare New Concepts in Integrative Care: Expert Insights on Cardiology’s Approach to Cardio-Renal-Metabolic Diseases 11:15 a.m.-12 p.m. | Learning Studio I SUPPORTER: Boehringer Ingelheim Pharmaceuticals, Inc. Product Theater for ZepboundTM (tirzepatide) Injection 12:30-1:15 a.m. | Learning Studio II SUPPORTER: Eli Lilly & Company INDUSTRY PROGRAMMING **Ticketed event Experience Scientific Sessions 2024 Final Program 65
RkJQdWJsaXNoZXIy MjI2NjI=